| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Mar―04 |
Fulminant myocarditis induced by SARS-CoV-2 infection without severe lung involvement: insights into COVID-19 pathogenesis |
Han Du, Zhongtao Du, Liang Wang, Hong Wang, Mingjun Jia, Chunge Zhang, et al. (+13) Yun Liu, Cheng Zhang, Ya Zhang, Ruifeng Zhang, Shuang Zhang, Ning Zhang, Zhenghai Ma, Chen Chen, Wenjun Liu, Hui Zeng, George F. Gao, Xiaotong Hou, Yuhai Bi |
| 2 |
[GO] |
2023―Oct―19 |
Humoral and cellular immunity against diverse SARS-CoV-2 variants |
Changxu Chen, Xin Wang, Zeli Zhang |
| 3 |
[GO] |
2022―Dec―06 |
Infection of SARS-CoV-2 causes severe pathological changes in mouse testis |
Min Chen, Shihua Li, Shujun Liu, Yuhang Zhang, Xiuhong Cui, Limin Lv, et al. (+5) Bowen Liu, Aihua Zheng, Qihui Wang, Shuguang Duo, Fei Gao |
| 4 |
[GO] |
2022―May―24 |
Pinpointing the animal origins of SARS-CoV-2: a genomic approach |
Shilei Zhao, Yali Hou, Xiaolong Zhang, Alice Hughes, Na Liu, Minsheng Peng, et al. (+3) Qihui Wang, Yongbiao Xue, Hua Chen |
| 5 |
[GO] |
2021―Dec―24 |
Evidence for a mouse origin of the SARS-CoV-2 Omicron variant |
Changshuo Wei, Ke-Jia Shan, Weiguang Wang, Shuya Zhang, Qing Huan, Wenfeng Qian |
| 6 |
[GO] |
2021―Nov―17 |
Alteration of the respiratory microbiome in COVID-19 patients with different severities |
Zhengtu Li, Yinhu Li, Linghua Li, Xiaoneng Mo, Shaoqiang Li, Mingzhou Xie, et al. (+12) Yangqing Zhan, Ye Lin, Zhun Li, Min Xie, Zhaoming Chen, Airu Zhu, Ruosu Ying, Le Yu, Jincun Zhao, Shuai Cheng Li, Weiping Cai, Feng Ye |
| 7 |
[GO] |
2021―Aug―23 |
An efficient metatranscriptomic approach for capturing RNA virome and its application to SARS-CoV-2 |
Yao Meng, Liwen Xiao, Wenbing Chen, Fangqing Zhao, Xiang Zhao |
| 8 |
[GO] |
2021―May―29 |
Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19 |
Rong Xu, Pengcheng Liu, Tao Zhang, Qunfu Wu, Mei Zeng, Yingying Ma, et al. (+4) Xia Jin, Jin Xu, Zhigang Zhang, Chiyu Zhang |
| 9 |
[GO] |
2021―Apr―21 |
The Challenge of Emerging SARS-CoV-2 Mutants to Vaccine Development |
Rong Li, Jun Liu, Hui Zhang |
| 10 |
[GO] |
2021―Mar―18 |
COVID-19 mRNA vaccines |
Qingrui Huang, Jiawei Zeng, Jinghua Yan |
| 11 |
[GO] |
2021―Feb―21 |
Genomic surveillance of Nevada patients revealed prevalence of unique SARS-CoV-2 variants bearing mutations in the RdRp gene |
Paul D. Hartley, Richard L. Tillett, David P. AuCoin, Joel R. Sevinsky, Yanji Xu, Andrew Gorzalski, et al. (+6) Mark Pandori, Erin Buttery, Holly Hansen, Michael A. Picker, Cyprian C. Rossetto, Subhash C. Verma |
| 12 |
[GO] |
2020―Nov―08 |
Dynamics of SARS-CoV-2 genome variants in the feces during convalescence |
Yi Xu, Lu Kang, Zijie Shen, Xufang Li, Weili Wu, Wentai Ma, et al. (+6) Chunxiao Fang, Fengxia Yang, Xuan Jiang, Sitang Gong, Li Zhang, Mingkun Li |
| 13 |
[GO] |
2020―Mar―17 |
Porcine reproductive and respiratory syndrome virus (PRRSV) inhibition with engineered Cas13d |
Guo Li, Xinjie Wang, Yajing Liu, Xinyuan Lv, Guanglei Li, Chengcheng Zhao, et al. (+3) Dandan Wang, Xingxu Huang, Xiaoxiang Hu |
| 14 |
[GO] |
2020―Feb―13 |
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines |
Xin Liu, Xiu-Jie Wang |
| 15 |
[GO] |
2020―Jan―30 |
Identification of potential cross-protective epitope between 2019-nCoV and SARS virus |
Tianyi Qiu, Tiantian Mao, Yuan Wang, Mengdi Zhou, Jingxuan Qiu, Jianwei Wang, et al. (+2) Jianqing Xu, Zhiwei Cao |
|
